Neonatal thermoregulation devices are used to regulate the body temperature of newborn infants, especially preterm babies. These devices help maintain the infant’s temperature within a safe physiological temperature range after delivery through external heating or cooling mechanisms. Main products in this category include non-invasive devices such as warmer mattresses, incubators, radiant warmers, and convective warmers. In addition to temperature control, advanced neonatal incubators and warmers also monitor vital parameters like heart rate, respiration rate and oxygen saturation levels. They provide a controlled environment with regulated humidity and oxygen levels to cater to the specific needs of fragile neonates. The global neonatal thermoregulation devices market plays a crucial role in neonatal and pediatric care given the risks associated with temperature fluctuations in young infants.
The global Neonatal Thermoregulation Devices Market is estimated to be valued at US$ 47.27 Mn in 2023 and is expected to exhibit a CAGR of 7.4% over the forecast period 2024 to 2031, as highlighted in a new report published by Coherent Market Insights.
Market key trends:
One of the key trends in the neonatal thermoregulation devices market is the growing adoption of innovative devices with advanced functionalities. Manufacturers are focusing on integrated solutions that can help automate temperature control operations while enabling remote patient monitoring capabilities. Some examples include closed-loop incubators that automatically adjust warming/cooling based on the infant’s temperature response, and network-connected devices that allow vital monitoring from a central station. Such innovative products help reduce workload for clinicians and improve care outcomes. Another major trend is the rising popularity of non-invasive radiant warmers and open cribs. Compared to conventional incubators, these new generation open-care devices provide a less sterile environment facilitating infant development with greater parental involvement in care processes.
Threat of new entrants: Low capital requirements and established industry players make entry difficult.
Bargaining power of buyers: Buyers have moderate bargaining power due to availability of alternative products.
Bargaining power of suppliers: A few large multinational corporations control supply, giving them significant influence over pricing.
Threat of new substitutes: Substitutes are emerging but neonatal thermoregulation is specialized with few direct alternatives.
Competitive rivalry: Intense competition among key global players to gain market share and develop innovative products.
The Global Neonatal Thermoregulation Devices Market Size is expected to witness high growth over the forecast period. The global Neonatal Thermoregulation Devices Market is estimated to be valued at US$ 47.27 Mn in 2023 and is expected to exhibit a CAGR of 7.4% over the forecast period 2024 to 2031.
North America holds the largest share of the global market and is expected to maintain its dominance during the forecast period. This can be attributed to the advanced healthcare infrastructure and growing neonatal population in the region.
Key players operating in the neonatal thermoregulation devices market are Sysmex Corporation (Japan), Danaher Corporation (US), Nihon Kohden (Japan), Siemens (Germany), Abbott (US), Boule Diagnostics (Sweden), HORIBA (Japan), Bio-Rad Laboratories (US), BioSystems (Spain), Diatron (Hungary), Drew Scientific (US), EKF Diagnostics (UK), Mindray (China), Ortho Clinical Diagnostics (US), and Roche (Switzerland), among others.
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it